Cancer Chronic Pain Predicted by Emotional and Cognitive Status
CompletedNCT02777697
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of this study is to investigate the predictive dimension of cognitive-emotional status of cancer patients on the chronic pain development 6 months after different cancer treatment protocol (surgery, chemotherapy, radiotherapy, hormone therapy, targeted therapy ...).
Study details
- Official title
- Cancer Chronic Pain Predicted by Emotional and Cognitive Status
- Conditions
- Interventions
- Other: chronic pain
- Sponsor
- University Hospital, Clermont-Ferrand
- Start date
- 2016-03
- Primary completion
- 2018-10-15
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- France
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age ≥ 18 years * Cancer patient with one or more programmed cancer treatment protocols (chemotherapy, surgery, hormone therapy, radiation therapy, targeted therapy, ...) * Acceptance to sign the non-opposition form Exclusion Criteria: * History of cancer and cancer treatment protocols (chemotherapy, surgery, hormone therapy, radiation therapy, targeted therapy, ...) * History and/or presence of primary brain tumors (glioblastoma, meningioma, neurofibroma ...) * History of neurological disorders (Parkinson's disease, Alzheimer's disease, dementia, epilepsy, moderate to severe head injury, ...) * History of psychiatric disorders (schizophrenia, bipolar disorder, ...) * Medical and surgical history incompatible with the study
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02777697